Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 15Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Glioblastoma 7Esophageal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Burkitt Lymphoma 7Uterine Cervical Neoplasms 6Rhabdomyosarcoma 6Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rectal Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Follicular 3Lung Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2

Interventions

Gemcitabine 18Cisplatin 13Oxaliplatin 8Capecitabine 7Leucovorin 6Fluorouracil 5pembrolizumab 4Photochemotherapy 3Irinotecan 3ivosidenib 2Cholangiopancreatography, Endoscopic Retrograde 2zanidatamab 1toripalimab 1pemigatinib 1lenvatinib 1infigratinib 1durvalumab 1cemiplimab 1becatecarin 1atezolizumab 1Tissue Adhesives 1Tegafur 1Taxes 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Platinum 1Pancreaticojejunostomy 1Nivolumab 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cholangiocarcinoma × Radiation × Clear all
NCT02773485 2022-10-21

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Tata Memorial Hospital

Phase 3 Unknown
155 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡